Racing to Develop a Potential COVID-19 Vaccine with Unprecedented Partnership

The current global scale of the COVID-19 pandemic requires nothing short of a fast-moving and nimble international effort to thwart it.

One such partnership is already underway. Pfizer has joined forces with German biotech company BioNTech to develop a potential RNA vaccine to prevent the spread of COVID-19. As we have already been working with the German partners since 2018 to develop an RNA influenza vaccine, we are well poised to quickly bring together our expertise to combat COVID-19.

Read the full article.